CARMEL, Ind., Oct. 17, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ('Syra Health' or the 'Company'), a healthcare company with a mission to improve healthcare by providing innovative services and technology solutions, announced today a two-year contract extension, worth up to $636,000, with the Indiana Division of Mental Health and Addiction and Family and Social Services Administration (FSSA) to chair and manage the State of Indiana's Epidemiological Outcomes Workgroup (SEOW)..

CARMEL，Ind。，2023年10月17日/PRNewswire/-Syra Health Corp.（纳斯达克股票代码：Syra）（'Syra Health'或'公司'），这是一家医疗保健公司，旨在通过提供创新服务改善医疗保健和技术解决方案，今天宣布延长两年合同，价值高达636000美元，与印第安纳州心理健康和成瘾以及家庭和社会服务管理局（FSSA）合作，主持和管理印第安纳州流行病学成果工作组（SEOW）。。

Through the contract extension, Syra Health will continue to collect and analyze substance use and misuse data throughout Indiana. Syra Health then develops data-driven reports and recommendations to inform and improve Indiana's long-term substance misuse prevention policy.

通过合同延期，Syra Health将继续收集和分析整个印第安纳州的物质使用和滥用数据。然后，Syra Health开发数据驱动的报告和建议，为印第安纳州的长期药物滥用预防政策提供信息和改进。

'Our qualitative and quantitative research methodologies and data-driven approaches to the SEOW contract helped us to secure this extension and have enabled us to win similar epidemiological study contracts in other states,' said Dr. Deepika Vuppalanchi, CEO, Syra Health.

Syra Health首席执行官Deepika Vuppalanchi博士说：“我们对SEOW合同的定性和定量研究方法和数据驱动方法帮助我们确保了这一扩展，并使我们能够赢得其他州类似的流行病学研究合同。

As part of this work, Syra Health's epidemiologists and public health experts identify emerging substance use trends in the state and promote behavioral and mental health improvements.

作为这项工作的一部分，Syra Health的流行病学家和公共卫生专家确定了该州新出现的物质使用趋势，并促进了行为和心理健康的改善。

'Working together with 20 different state agencies and divisions, we have the unique opportunity to provide a holistic picture of the behavioral health needs for the State of Indiana,' said Dr. Srikant Devaraj , Vice President of Health Analytics, Syra Health.

Syra health健康分析副总裁Srikant Devaraj博士说：“与20个不同的州机构和部门合作，我们有独特的机会全面了解印第安纳州的行为健康需求。

ABOUT SYRA HEALTH CORP.

关于锡拉健康公司。

Syra Health is a healthcare company with a mission to improve healthcare by providing innovative services and technology solutions. Syra Health aims to achieve its goal by becoming a valuable partner to government, payers, providers, life sciences organizations, and academic institutions. Syra Health offers products and services in digital health, behavioral and mental health, population health management, health education, and healthcare workforce.

Syra Health是一家医疗保健公司，其使命是通过提供创新的服务和技术解决方案来改善医疗保健。Syra Health旨在通过成为政府，付款人，提供者，生命科学组织和学术机构的宝贵合作伙伴来实现其目标。Syra Health在数字健康，行为和心理健康，人口健康管理，健康教育和医疗保健人员中提供产品和服务。

For more information, please visit www.syrahealth.com.  .

欲了解更多信息，请访问www.syrahealth.com。

SAFE HARBOR STATEMENT

安全港声明

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results.

本新闻稿中有关未来预期，计划和前景的声明，以及关于非历史事实事项的任何其他声明，可能构成“前瞻性声明”这些陈述包括但不限于与预期使用收益，公司运营和业务战略以及公司预期财务成果有关的陈述。

The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

“预期”，“相信”，“继续”，“可能”，“估计”，“期望”，“打算”，“可能”，“计划”，“潜力”，“预测”，“项目”，“应该”，“目标”，“将会”和类似的表达方式是为了识别前瞻性陈述，尽管并非所有的前瞻性陈述都包含这些识别词语。

The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in the 'Risk Factors' section of the prospectus filed with the SEC.

本新闻稿中包含的前瞻性声明基于管理层当前的预期，并存在重大风险，不确定性和环境变化。由于向证券交易委员会提交的IPO“风险因素”部分讨论了各种重要因素，实际结果可能与此类前瞻性陈述所表明的结果大不相同。

Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise..

本新闻稿中包含的任何前瞻性声明仅在本声明发布之日起发言，除联邦证券法要求外，本公司明确拒绝更新任何前瞻性声明的任何义务，无论是由于新信息，未来事件或其他方面。。

For more information, please contact:

欲了解更多信息，请联系：

For Media Inquiries:Christine DruryCommunications and Marketing DirectorSyra Health Corp.463-345-5180[email protected]

媒体查询：Christine DruryCommunications和营销总监Syra Health Corp.463-345-5180[电子邮件保护]

For Investor Inquiries:Ben ShamsianVice PresidentLytham Partners, LLC646-829-9701[email protected]

投资者查询：Ben ShamsianVice主席Lytham Partners，LLC646-829-9701[电子邮件保护]

SOURCE Syra Health

来源Syra健康